As Israel celebrates 60 years of statehood, American investors may be looking to invest in shares of Israeli companies. Haim Israel of Merrill Lynch in Jerusalem has some ideas about smaller companies that may have escaped the attention of U.S. investors.
Everyone knows about generic pharmaceutical giant Teva, but what other promising investments lie on the eastern shore of the Mediterranean?
"I'll start with Cellcom, which is the market leader in terms of cellular providers," Haim Israel told CNBC.
"It saw a massive increase in revenues, net income -- more than doubled its net income this year -- and we expect the trend to continue."
Disclosure information for Haim Israel was not immediately available.